Related Experiment Video
Updated: Apr 18, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
Treating COPD in Older and Oldest Old Patients
Andrea Corsonello, Simone Scarlata, Claudio Pedone
1Unit of Geriatric Pharmacoepidemiology, IRCCS-INRCA, Cosenza, Italy. andrea_corsonello@tin.it.
Managing COPD in older adults requires personalized treatment focusing on physical function. Tailored therapies, including bronchodilators and non-pharmacological interventions, are crucial for improving outcomes in this complex patient group.
Area of Science:
- Geriatrics
- Pulmonology
- Pharmacology
Background:
- Older adults with COPD present unique treatment challenges due to impaired homeostasis and reduced functional reserve.
- Managing chronic obstructive pulmonary disease (COPD) in the elderly necessitates careful consideration of age-related physiological changes.
Purpose of the Study:
- To review the difficulties in managing COPD therapy in older and oldest old patients.
- To identify potential remedies and optimize treatment strategies for elderly COPD patients.
Main Methods:
- Systematic review of current therapeutic approaches for COPD in elderly populations.
- Analysis of pharmacological treatments (LABA, LAMA, ICS), long-term oxygen therapy (LTOT), and non-pharmacological interventions.
- Evaluation of the impact of comorbidities, polypharmacy, and patient-specific factors on treatment decisions.
Main Results:
- Pharmacological response and safety of inhaled long-acting beta-agonists (LABA) and anticholinergics (LAMA) may differ in older patients with multimorbidity.
- Non-pharmacological interventions like pulmonary rehabilitation and telemonitoring significantly improve outcomes.
- Careful assessment of cognitive status, comorbidities, and adherence factors is essential for effective COPD management in the elderly.
Conclusions:
- Treatment for older COPD patients must be individualized, considering functional status, comorbidities, and potential drug interactions.
- Optimizing inhaler device selection and addressing adherence risks are critical.
- Palliative care and management of exacerbations require a comprehensive, age-sensitive approach.
More Related Videos
04:24Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
Published on: September 5, 2025
04:53Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment